Mirae Asset Global ETFs Holdings’s Ocular Therapeutix OCUL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$931K	Buy	94,818 +6,648	+8%	+$60.3K	﹤0.01%	1671
2026 Q1	$747K	Buy	88,170 +1,776	+2%	+$16.9K	﹤0.01%	1667
2025 Q4	$1.05M	Buy	86,394 +21,413	+33%	+$260K	﹤0.01%	1492
2025 Q3	$760K	Sell	64,981 -12,053	-16%	-$144K	﹤0.01%	1656
2025 Q2	$715K	Sell	77,034 -16,585	-18%	-$130K	﹤0.01%	1620
2025 Q1	$686K	Buy	93,619 +5,156	+6%	+$39.6K	﹤0.01%	1687
2024 Q4	$755K	Buy	88,463 +2,853	+3%	+$27.8K	﹤0.01%	1701
2024 Q3	$745K	Buy	85,610 +27,038	+46%	+$223K	﹤0.01%	1718
2024 Q2	$401K	Buy	+58,572	New	+$362K	﹤0.01%	1924

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's OCUL Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Ocular Therapeutix (OCUL) stake by 7.5% in Q2 2026, buying an estimated $60.3K and bringing the position to 94,818 shares worth $931K. The position accounts for ﹤0.01% of the portfolio, ranked #1671.

Mirae Asset Global ETFs Holdings first reported a position in OCUL in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.05M in Q4 2025. 261 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

Mirae Asset Global ETFs Holdings held 94,818 shares of Ocular Therapeutix worth $931K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 6,648 Ocular Therapeutix shares in Q2 2026, an estimated $60.3K.
Ocular Therapeutix made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1671 holding.
Mirae Asset Global ETFs Holdings first reported a position in Ocular Therapeutix in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Ocular Therapeutix position peaked at $1.05M in Q4 2025.
261 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.